Brigham & Women's Hospital
HIV/AIDS healthcare infrastructure helps decrease risk of drug resistance
Published in Physician Business Week, October 12th, 2004
According to scientists writing in the journal AIDS, "The emergence of drug resistance in human immunodeficiency virus type 1 (HIV-1) may limit the clinical benefits of antiretroviral therapy."
"There is no objective evidence that the risk of drug resistance is greater in resource-limited settings than in the developed world," D.R. Kuritzkes and colleagues said.
"Treatment programs will be most successful at preventing the spread of drug resistance if they provide healthcare infrastructures to maximize the effectiveness of antiretroviral therapy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- CryoLife, Inc.
Biosurgical device company presented results of SynerGraft arteriovenous device - Finance
Amedisys announces pricing of $67.7M follow-on offering - RITA Medical Systems, Inc.
CIGNA HealthCare will cover radiofrequency ablation liver treatment - Aachen University Hospital, Germany
Cochlear implantation in the elderly enhances quality of life - Aichi Cancer Center
Polymorphism increases disease risk in some premenopausal Japanese women - Awards
Hospitalists receive 2004 John M. Eisenberg Patient Safety and Quality Awards - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
